Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells.
The effect of lymphocyte subsets, separated on the basis of cell density, on Epstein-Barr virus (EBV)-induced B-cell proliferation was studied. The experiments were performed with lymphocytes of seropositive individuals. After 2 weeks of culture, the growth of B cells was inhibited by the T subset, which is also active in natural killer assays, i.e., the low-buoyant density lymphocyte fractions. However, if the cultures were observed for a longer time, the initial growth regressed even in cultures containing the subsets which did not have natural killing (NK) function, i.e., those with high cell density. The initial cell concentration at which the cultures were seeded determined the outcome of the experiments and the demonstration of inhibitory effects. An important difference was seen between the subsets with regard to radiosensitivity. The prompt inhibitory effect of the NK-positive subset remained after irradiation, while the function of the NK-negative one was abrogated. In the presence of the irradiated T-enriched total population, infected B cells (BEBV) grew. Consequently, the radiation-resistant effector compartment, represented by the low-density cells, was not sufficient to counteract the establishment of BEBV lines. They contributed, nevertheless, to the regression because the kinetics of B-cell growth were different in cultures containing separated high-density cells or the total population. In the former, growth continued for a longer time and complete regression occurred only in the cultures initiated with high cell concentrations. The experiments showed that two types of cells contribute to the regression of BEBV growth in cultures initiated with lymphocytes of seropositive donors. One acts promptly and is independent of cell proliferation; another is activated for proliferation by encounter with B blasts.
D002455:Cell Division; D002472:Cell Transformation, Viral; D003602:Cytotoxicity, Immunologic; D004854:Herpesvirus 4, Human; D007111:Immunity, Cellular; D007694:Killer Cells, Natural / Q000276:immunology; D007700:Kinetics; D008214:Lymphocytes / Q000166:cytology / Q000276:immunology*